alain moreau

  1. Nightsong

    Haptoglobin phenotypes and structural variants associate with post-exertional malaise and cognitive dysfunction in [ME], 2025, Moezzi, Moreau et al

    Abstract: Background Myalgic encephalomyelitis (ME) is a chronic, multisystem illness characterized by post-exertional malaise (PEM) and cognitive dysfunction, yet the molecular mechanisms driving these hallmark symptoms remain unclear. This study investigated haptoglobin (Hp) as a potential...
  2. Nightsong

    SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis, 2025, Moreau, Fluge, Mella et al

    Abstract: Background Sphingomyelin phosphodiesterase acid-like 3B (SMPDL3B) is emerging as a potential biomarker and therapeutic target in myalgic encephalomyelitis (ME), a complex multisystem disorder characterized by immune dysfunction, metabolic disturbances, and persistent fatigue. This...
  3. SNT Gatchaman

    2023 IIMEC15 - Alain Moreau

    YouTube: IIMEC15 07 Professor Alain Moreau 15th Invest in ME Research International ME Conference 2023 Discussion of potential biomarkers in ME/LC subgroups. References upcoming, unpublished work. Highlighted time-stamps — 9:07 MicroRNAs 18:18 SMPDL3B 27:03 FGF-21 SMPDL3B is Sphingomyelin...
  4. ahimsa

    Healthy Debate: Groundbreaking research into ME/CFS a pandemic ‘silver lining’

    Groundbreaking research into ME/CFS a pandemic ‘silver lining’ https://healthydebate.ca/2022/12/topic/research-mecfs-pandemic-silver-lining/
Back
Top Bottom